SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001299933-11-001376
Filing Date
2011-05-06
Accepted
2011-05-06 10:40:12
Documents
8
Period of Report
2011-05-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_41621.htm 8-K 27562
2 EX-10.1 exhibit1.htm EX-10.1 122062
3 EX-10.2 exhibit2.htm EX-10.2 41566
4 EX-10.3 exhibit3.htm EX-10.3 47524
5 EX-10.4 exhibit4.htm EX-10.4 33870
6 EX-10.5 exhibit5.htm EX-10.5 40388
7 EX-99.1 exhibit6.htm EX-99.1 34431
8 GRAPHIC e33413-1112523591320b5071_1.jpg GRAPHIC 12335
  Complete submission text file 0001299933-11-001376.txt   366051
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS INC (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32335 | Film No.: 11817316
SIC: 2836 Biological Products, (No Diagnostic Substances)